Statin therapy, muscle function and vitamin D

QJM: An International Journal of Medicine

Volumn 102, Issue 12, 2009, Pages 890-891

  Goldstein, M R ^a   Mascitelli, L ^b   Pezzetta, F ^c  

^a Fountain Medical Court Bonita   (United States)

^b Medical Service   (Italy)

^c Ospedale Civile di Tolmezzo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLECALCIFEROL; STATIN; VITAMIN D; VITAMIN D RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

FALLING; HUMAN; LETTER; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE STRENGTH; MYALGIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUALITY OF LIFE; RISK FACTOR; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; AGED; BLOOD; FRAIL ELDERLY; MUSCLE WEAKNESS; NOTE;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; FRAIL ELDERLY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCLE WEAKNESS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77950583021     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp123     Document Type: Letter

References (18)

1. Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. Q J Med 2009; 102:625-33.
2. Roukoniemi P, Helin-Salmivaara A, Klaukka T, Neuvonen PJ, Huupponen R. Shift of statin use towards the elderly in 1995-2005: a nation-wide register study in Finland. Br J Pharmacol 2008; 66:405-10.
3. Marcell TJ. Sarcopenia: causes, consequences, and preventions. J Gerontol Med Sci 2003; 58A:911-16.
4. 3: past, present and future. J Bone Miner Res 1998; 13:1360-9.
5. Dawson-Hughes B. Serum 25-hydroxyvitamin D and functional outcomes in the elderly. Am J Clin Nutr 2008; 88:537S-40S.
6. Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, Goldenberg N, et al. Low serum 25(OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009; 153:11-16.
7. Lee P, Greenfield JR, Campbell LV. Vitamin D insufficiency - a novel mechanism of statin-induced myalgia? Clin Endocrinol 2009; 71:154-6.
8. Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in Western New York. Arch Intern Med 2000; 160:1199-203.
9. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291:1999-2006.
10. Ginde AA, Liu MC, Camargo Jr CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-32.
11. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85:860-8.
12. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18-28.
13. 2) as a vitamin supplement. Am J Clin Nutr 2006; 84:694-7.
14. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81:353-73.
15. Heaney RP. The case for improving vitamin D status. J Steroid Biochem Mol Biol 2007; 103:635-41.
16. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxy-cholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77:204-10.
17. Goldstein MR, Mascitelli L, Pezzetta F. Statin therapy in the elderly: misconceptions. J Am Geriatr Soc 2008; 56:1365.
18. Ginde AA, Scragg R, Schwartz RS, Camargo Jr CA. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009 [Epub ahead of print; doi: 10.111/j.1532-5415.2009.02359.x].